<?xml version='1.0' encoding='utf-8'?>
<document id="25903969"><sentence text="Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential."><entity charOffset="0-9" id="DDI-PubMed.25903969.s1.e0" text="Biochanin" /></sentence><sentence text="Use of dietary products is on the rise due to health benefits associated with the ingestion of flavonoids contained in them"><entity charOffset="95-105" id="DDI-PubMed.25903969.s2.e0" text="flavonoids" /></sentence><sentence text=" Biochanin A (BioA) is the major constituent of red clover extract and has undergone investigations for health benefits and drug interaction potential"><entity charOffset="1-12" id="DDI-PubMed.25903969.s3.e0" text="Biochanin A" /></sentence><sentence text=" In many instances, BioA has exhibited a clear anomaly in the in vivo pharmacokinetics of co-administered drugs which were contrary to the in vitro studies" /><sentence text=" The focus of this review is to critically evaluate several mechanisms that may come into play for the interpretation of the in vivo pharmacokinetic data of drugs co-administered with BioA" /><sentence text=" " /></document>